|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/28 | |
| A61K 39/395 | |||
| C07K 14/71 |
| (11) | Patento numeris | 2132229 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 08706941.5 |
| Europos patento paraiškos padavimo data | 2008-02-27 | |
| (97) | Europos patento paraiškos paskelbimo data | 2009-12-16 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2016-05-11 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/DK2008/050047 |
| Data | 2008-02-27 |
| (87) | Numeris | WO 2008/104183 |
| Data | 2008-09-04 |
| (30) | Numeris | Data | Šalis |
| 200700317 | 2007-03-01 | DK | |
| 904773 P | 2007-03-05 | US | |
| 200701016 | 2007-07-10 | DK | |
| 929727 P | 2007-07-11 | US |
| (72) |
PEDERSEN, Mikkel, Wandahl, DK
STEINAA, Lucilla, DK
JENSEN, Allan, DK
KOEFOED, Klaus, DK
MEIJER, Per-Johan, DK
CARLSSON, Robert, SE
PYKE, Charles, DK
NIELSEN, Lars, Soegaard, DK
|
| (73) |
Symphogen A/S,
Pederstrupvej 93, 2750 Ballerup,
DK
|
| (54) | RECOMBINANT ANTI-EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY COMPOSITIONS |
| RECOMBINANT ANTI-EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY COMPOSITIONS |